Pharmacological Reviews

Papers
(The H4-Index of Pharmacological Reviews is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies386
Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options374
Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels247
Is Oxytocin “Nature’s Medicine”?198
RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges192
Rescuing the Last-Line Polymyxins: Achievements and Challenges174
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development160
Subcellular Organization of the cAMP Signaling Pathway143
International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function136
The Noncanonical Pathway for In Vivo Nitric Oxide Generation: The Nitrate-Nitrite-Nitric Oxide Pathway134
Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials117
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms108
Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics98
Matrix Metalloproteinases: From Molecular Mechanisms to Physiology, Pathophysiology, and Pharmacology98
Pharmacological Inhibition of the Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome with MCC95089
Sex- and Gender-Based Pharmacological Response to Drugs86
Post-Translational Modifications of G Protein–Coupled Receptors Control Cellular Signaling Dynamics in Space and Time86
On the Clinical Pharmacology of Reactive Oxygen Species72
Sex Differences in Opioid and Psychostimulant Craving and Relapse: A Critical Review68
International Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update68
Structure-Based Virtual Screening for Ligands of G Protein–Coupled Receptors: What Can Molecular Docking Do for You?66
Mutations in G Protein–Coupled Receptors: Mechanisms, Pathophysiology and Potential Therapeutic Approaches63
International Union of Basic and Clinical Pharmacology. CVIII. Calcium-Sensing Receptor Nomenclature, Pharmacology, and Function62
Animal Models of Drug Relapse and Craving after Voluntary Abstinence: A Review61
Unlocking G-Quadruplexes as Antiviral Targets61
Ontogeny of Hepatic Transporters and Drug-Metabolizing Enzymes in Humans and in Nonclinical Species61
Sex Differences in the Epilepsies and Associated Comorbidities: Implications for Use and Development of Pharmacotherapies60
E1 Enzymes as Therapeutic Targets in Cancer58
Dopamine, Immunity, and Disease56
Hydroxynorketamines: Pharmacology and Potential Therapeutic Applications56
Aldo-Keto Reductases and Cancer Drug Resistance55
Inhaled Medicines: Past, Present, and Future46
Strategies to Modulate MicroRNA Functions for the Treatment of Cancer or Organ Injury44
Therapeutic Targeting of α7 Nicotinic Acetylcholine Receptors41
Therapeutics in the Pipeline Targetingα-Synuclein for Parkinson's Disease41
Neurobiological Mechanisms of Nicotine Reward and Aversion40
Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications39
Nonantimicrobial Actions of Macrolides: Overview and Perspectives for Future Development39
ATP and Adenosine Metabolism in Cancer: Exploitation for Therapeutic Gain38
0.017999887466431